Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Rizzo

Showing results (191-200 of 381) with videos related to

Pageof 39
Sort By:
Expert Opinion on Investigational Drugs|November 22, 2021
Immune-based combinations for metastatic triple negative breast cancer in clinical trials: current knowledge and therapeutic prospectsAlessandro Rizzo, Angela Dalia Ricci, Laura Lanotte, et al.
Advanced Theory and Simulations|September 13, 2021
Designing the Safe Reopening of US Towns Through High-Resolution Agent-Based ModelingAgnieszka Truszkowska, Malav Thakore, Lorenzo Zino, et al.
Expert Opinion on Drug Metabolism & Toxicology|August 19, 2021
Risk of cardiovascular toxicities and hypertension in nonmetastatic castration-resistant prostate cancer patients treated with novel hormonal agents: a systematic review and meta-analysisAlessandro Rizzo, Sara Merler, Giulia Sorgentoni, et al.
Cancers|April 30, 2021
Novel HER2-Directed Treatments in Advanced Gastric Carcinoma: AnotHER Paradigm Shift?Angela Dalia Ricci, Alessandro Rizzo, Fabiola Lorena Rojas Llimpe, et al.
Cancer Treatment Reviews|April 17, 2026
Multigene assays in early breast cancer: Current evidence, limits and future directionsEmanuela Fina, Vincenzo Di Lauro, Alessandro Rizzo, et al.
Anti-Cancer Drugs|December 8, 2020
Prognostic and predictive factors to nivolumab in patients with metastatic renal cell carcinoma: a single center studyVeronica Mollica, Alessandro Rizzo, Elisa Tassinari, et al.
Medicines (Basel, Switzerland)|January 14, 2021
Encephalic Leukocytoclastic Vasculitis during Treatment with Sunitinib for Renal Cell Carcinoma: A Case ReportMaria Massucci, Veronica Mollica, Alessandro Rizzo, et al.
Future Oncology (London, England)|June 12, 2024
Sacituzumab govitecan vs. chemotherapy for metastatic breast cancer: a meta-analysis on safety outcomesAlessandro Rizzo, Lucia Rinaldi, Raffaella Massafra, et al.
Expert Opinion on Drug Metabolism & Toxicology|January 14, 2022
Peripheral neuropathy and headache in cancer patients treated with immunotherapy and immuno-oncology combinations: the MOUSEION-02 studyAlessandro Rizzo, Matteo Santoni, Veronica Mollica, et al.
Expert Review of Anticancer Therapy|May 15, 2023
Adapting to hormone-therapy resistance for adopting the right therapeutic strategy in advanced prostate cancerGiacomo Nuvola, Matteo Santoni, Mimma Rizzo, et al.
Pageof 39

Showing results (191-200 of 381) with videos related to

Sort By:
Pageof 39
Expert Opinion on Investigational Drugs|November 22, 2021
Immune-based combinations for metastatic triple negative breast cancer in clinical trials: current knowledge and therapeutic prospectsAlessandro Rizzo, Angela Dalia Ricci, Laura Lanotte, et al.
Advanced Theory and Simulations|September 13, 2021
Designing the Safe Reopening of US Towns Through High-Resolution Agent-Based ModelingAgnieszka Truszkowska, Malav Thakore, Lorenzo Zino, et al.
Expert Opinion on Drug Metabolism & Toxicology|August 19, 2021
Risk of cardiovascular toxicities and hypertension in nonmetastatic castration-resistant prostate cancer patients treated with novel hormonal agents: a systematic review and meta-analysisAlessandro Rizzo, Sara Merler, Giulia Sorgentoni, et al.
Cancers|April 30, 2021
Novel HER2-Directed Treatments in Advanced Gastric Carcinoma: AnotHER Paradigm Shift?Angela Dalia Ricci, Alessandro Rizzo, Fabiola Lorena Rojas Llimpe, et al.
Cancer Treatment Reviews|April 17, 2026
Multigene assays in early breast cancer: Current evidence, limits and future directionsEmanuela Fina, Vincenzo Di Lauro, Alessandro Rizzo, et al.
Anti-Cancer Drugs|December 8, 2020
Prognostic and predictive factors to nivolumab in patients with metastatic renal cell carcinoma: a single center studyVeronica Mollica, Alessandro Rizzo, Elisa Tassinari, et al.
Medicines (Basel, Switzerland)|January 14, 2021
Encephalic Leukocytoclastic Vasculitis during Treatment with Sunitinib for Renal Cell Carcinoma: A Case ReportMaria Massucci, Veronica Mollica, Alessandro Rizzo, et al.
Future Oncology (London, England)|June 12, 2024
Sacituzumab govitecan vs. chemotherapy for metastatic breast cancer: a meta-analysis on safety outcomesAlessandro Rizzo, Lucia Rinaldi, Raffaella Massafra, et al.
Expert Opinion on Drug Metabolism & Toxicology|January 14, 2022
Peripheral neuropathy and headache in cancer patients treated with immunotherapy and immuno-oncology combinations: the MOUSEION-02 studyAlessandro Rizzo, Matteo Santoni, Veronica Mollica, et al.
Expert Review of Anticancer Therapy|May 15, 2023
Adapting to hormone-therapy resistance for adopting the right therapeutic strategy in advanced prostate cancerGiacomo Nuvola, Matteo Santoni, Mimma Rizzo, et al.
Pageof 39